Aldatu Biosciences

Aldatu Biosciences specializes in adaptive PCR diagnostics for global health, epidemic prevention, preparedness, and response. Aldatu’s core strength lies in our unyielding motivation to deliver infectious disease diagnostics that enhance public health outcomes in low-and middle-income countries using PANDAA, our proprietary platform technology that overcomes diagnostic challenges posed by viral genetic diversity. To date, Aldatu has secured >$20 million in non-dilutive funding from the NIH. The company maintains ISO 13485 certification, affirming compliance with rigorous international standards for medical device manufacturing.